期刊
OSTEOARTHRITIS AND CARTILAGE
卷 19, 期 4, 页码 346-353出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.joca.2011.02.002
关键词
Osteoarthritis; Biomarkers
资金
- NIAMS NIH HHS [5P01-AR050245, P01 AR050245-08, P01 AR050245, P01 AR050245-09] Funding Source: Medline
- NIA NIH HHS [P30 AG028716, 5P30-AG028716-05, P30 AG028716-05] Funding Source: Medline
At the 2010 Osteoarthritis Research Society International (OARS!) congress in Brussels I was asked to present on Biochemical Markers in the Year in Review session. This provided an opportunity to summarize ongoing work and consensus building in the osteoarthritis research community related to osteoarthritis biomarkers, and second, and an opportunity to briefly overview a subset of studies from the previous 12 months related to soluble biomarkers that provided novel insights in the field. This review therefore briefly summarizes the progress in 2010 of the OARSI OA Biomarkers Global Initiative and the OARSI FDA Biomarkers Working Group, and provides a summary of selected osteoarthritis biomarker studies reported over the previous 12 months based on a review of articles from seven musculoskeletal journals and a PubMed search using the terms biomarkers and osteoarthritis. (C) 2011 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据